一般演題(ポスター)
血小板/Platelet・VWF

[P-049] Pharmacokinetics of Recombinant VWF in Patients with Type 3 VWD: Role of Large and Ultra-Large Multimers

^○Hitoshi Ueda¹, Bettina Ploder², Herbert Gritsch², Margit Stimpfl², Ulrich Budde³, Björn Mellgård⁴, Bruce Ewenstein⁴, Françoise Truong Berthoz⁵, Peter Turecek² (1.Japan Medical Office, Takeda Pharmaceutical Company Limited, Japan, 2.Baxalta Innovations GmbH, a Takeda company, Austria, 3.Medilys Laboratory Association, Germany, 4.Baxalta US Inc., a Takeda company, United States of America, 5.Baxalta GmbH, a Takeda company, Switzerland)

Keywords:VWF